Active	Status	Sponsor type	Region	Phase	Filter
10 Active 1 Inactive 11 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

10 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kella, Naveen
CLARIFY, NCT06056830: Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy	Recruiting	3	383	US, RoW	64Cu-SAR-bisPSMA	Clarity Pharmaceuticals Ltd	Prostate Cancer, Prostatic Neoplasms	02/25	02/25
CAPTAIN, NCT05027477: A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer	Recruiting	N/A	201	Europe, Canada, US	Radical Prostatectomy, TULSA Procedure, TULSA-PRO	Profound Medical Inc.	Prostate Cancer, Prostate Adenocarcinoma	12/24	12/34
NCT06217328: RESTORE: An RCT to Evaluate the Efficacy of the Revi System	Recruiting	N/A	150	US	Revi System Treatment, Revi System - Delayed Activation	BlueWind Medical	Urinary Urge Incontinence	05/26	05/27
NCT04757116: Post-Market Study to Assess iTind Safety in Comparison to UroLift	Recruiting	N/A	206	Europe, US	iTind, UroLift	Olympus Corporation of the Americas	Benign Prostatic Hyperplasia (BPH)	12/25	12/30
CARE, NCT05001477: Customized TULSA-PRO Ablation Registry	Recruiting	N/A	1000	US	TULSA Procedure	Profound Medical Inc.	Prostate Cancer, Prostate Adenocarcinoma, Benign Prostatic Hyperplasia	10/26	10/61
VAPOR 2, NCT05683691: Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer	Active, not recruiting	N/A	400	US	Vanquish System	Francis Medical Inc.	Prostate Cancer	04/27	04/29
Villarreal, Esmeralda
OPTI-2, NCT06238778: Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec	Recruiting	2	230	US	HDV-Lispro, HDV-L, Lispro, LIS	Diasome Pharmaceuticlas, Inc.	Diabetes Mellitus, Type 1	06/25	12/25
CARE, NCT05001477: Customized TULSA-PRO Ablation Registry	Recruiting	N/A	1000	US	TULSA Procedure	Profound Medical Inc.	Prostate Cancer, Prostate Adenocarcinoma, Benign Prostatic Hyperplasia	10/26	10/61
Arnold, Jenny
CAPTAIN, NCT05027477: A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer	Recruiting	N/A	201	Europe, Canada, US	Radical Prostatectomy, TULSA Procedure, TULSA-PRO	Profound Medical Inc.	Prostate Cancer, Prostate Adenocarcinoma	12/24	12/34
Dunshee, Ann
CARE, NCT05001477: Customized TULSA-PRO Ablation Registry	Recruiting	N/A	1000	US	TULSA Procedure	Profound Medical Inc.	Prostate Cancer, Prostate Adenocarcinoma, Benign Prostatic Hyperplasia	10/26	10/61